DOCSLIB.ORG

Mir-506-3P Suppresses the Proliferation of Ovarian Cancer Cells by Negatively Regulating the Expression of MTMR6

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mir-506-3P Suppresses the Proliferation of Ovarian Cancer Cells by Negatively Regulating the Expression of MTMR6 J Biosci (2019) 44:126 Ó Indian Academy of Sciences DOI: 10.1007/s12038-019-9952-9 (0123456789().,-volV)(0123456789().,-volV) MiR-506-3p suppresses the proliferation of ovarian cancer cells by negatively regulating the expression of MTMR6 YUAN WANG,XIA LEI,CHENGYING GAO,YANXIA XUE,XIAOLIN LI,HAIYING WANG and YAN FENG* Department of Gynaecology, Yan’an University Affiliated Hospital, Yanan, Shaanxi Province, China *Corresponding author (Email, [email protected]) MS received 10 February 2019; accepted 26 July 2019; published online 22 October 2019 MicroRNAs have been reported to play a crucial role in ovarian cancer (OC) as the most lethal malignancy of the women. Here, we found miR-506-3p was significantly down-regulated in OC tissues compared with corresponding adjacent non- tumor tissues. Ectopic miR-506-3p expression inhibited OC cell growth and proliferation using MTT and colony formation assay. Additionally, flow cytometry analysis showed that the overexpression of miR-506-3p induced cell cycle G0/G1 phase arrest and cell apoptosis in OC cells. A luciferase reporter assay confirmed that the myotubularin-related protein 6 (MTMR6) was the target of miR-506-3p. The expression of MTMR6 was increased in OC tissues compared with adjacent tissues using immunohistochemistry. Elevated MTMR6 protein levels were confirmed in OC cells lines compared with immortalized fallopian tube epithelial cell line FTE187 using western blotting. In addition, knockdown of MTMR6 imitated the effects of miR-506-3p on cell proliferation, cell cycle progression and apoptosis in OC cells. Furthermore, rescue experiments using MTMR6 overexpression further verified that MTMR6 was a functional target of miR-506-3p. Our data indicate that miR-506-3p might serve as a tumor suppressor gene and propose a new regulatory mechanism of MTMR6 by miR-506-3p in OC. Keywords. Apoptosis; cell proliferation; miR-506-3p; MTMR6; ovarian cancer 1. Introduction binding predominantly to 30UTR of target mRNAs, micro- RNAs play a crucial role in fundamental cellular processes, In developed countries, ovarian cancer (OC) related mor- such as proliferation, differentiation, migration, apoptosis, tality currently account for more than any other female and tissue specific functions including angiogenesis, hor- genital tract tumors (McAlpine et al. 2014). Each year about mone production and innate immune response (Liz and 22,440 women will experience OC, and 14,080 deaths are Esteller 2016; Kim et al. 2017). The evident connection expected to occur in the United States (Siegel et al. 2017). between microRNA dysregulation and cancer was discov- OC typically presents with a few months of post-menopausal ered in 2002 (Acunzo et al. 2015). From then on, numerous bleeding, persistent pelvic, abdominal pain and distension information regarding the role of microRNAs in cancer (Brain et al. 2014). Despite the international standard of care tumorigenesis and drug resistance has been gained (Zhao for high-grade serous OC is surgery and platinum-based et al. 2015). MicroRNA-506-3p (miR-506-3p), a component cytotoxic chemotherapy, whereas the overall survival of of the X chromosome-linked cluster in the primate testis, these patients have not changed significantly for several was found to be involved in multiple physiological and decades (Kehoe et al. 2015). Recent epigenetic studies have pathological procedures in several human tumors (Huang challenged the traditional view on the pathomechanism of et al. 2017; Wu et al. 2018). The pleiotropic activities and OC, implying that microRNAs may be both cause and tumor-specific contributions of miR-506-3p to various can- consequences of aberrant epigenetic events in OC (Ramas- cer development and progression are achieved by binding to sone et al. 2018). its specific target genes (Wen et al. 2015; Guo et al. 2017). MicroRNAs are an evolutionarily conserved classical of Though miR-506-3p has recently been demonstrated to act short, regulatory non-coding RNAs (*22 nucleotides) that as tumor suppressor in non-small lung cancer (Guo et al. acts to negatively regulate transcripts expression of both 2017), retinoblastoma (Wu et al. 2018), cervical cancer coding and non-coding genes (Langhe 2015). Lately, more (Wen et al. 2015), and osteosarcoma (Jiashi et al. 2018). than 2588 mature human microRNAs have been discovered However, the role of miR-506-3p in OC remains to be and the list is growing (Strmsek and Kunej 2015). By elucidated. http://www.ias.ac.in/jbiosci 1 126 Page 2 of 11 Yuan Wang et al. The myotubularin (MTM)-related protein family in humans Table 1. Clinicopathological features of ovarian cancer patients consists of 14 members with specificity for phosphatidylinos- (n = 20) itol 3-phosphate (PtdIns3P) and PtdIns (3,5) (Clague and Lorenzo 2005). Members of this family encode a central pro- Clinical pathologic parameters Cases (n = 20) tein tyrosine phosphatase domain (PTP), pleckstrin homology/ Age GRAM (PH/G) and coiled-coil (CC) domains (Choudhury \50 8 et al. 2006). Several studies have been published in recent years C50 12 that the malignant biological behaviors are regulated by MTMs Tumor size (cm) \415 (Yoo et al. 2004). For instance, myotubularin-related protein 3 C45 (MTMR3) is responsible for miR-99a-mediated regulation of FIGO stage oral cancer cells proliferation, migration and invasion (Kuo I/II 14 et al. 2014). By using new software for cell tracking, Oppelt III/IV 6 et al. (2014) observed that MTMR3 deficiency caused severe Histological grade Low 9 reduction in velocity in three cancer cell lines. In colorectal Moderate 6 cancer, MTMR7 overexpression resulted in the inactivation of High 5 insulin-mediated AKT-ERK signaling and proliferation (Wei- dner et al. 2016). MTMR6 could negatively regulate Ca2?- FIGO federation of gynecology and obstetrics ? activated K channel KCa3.1 which implicate in the prolifer- ative activity of some cancer cells (Srivastava et al. 2005). A recent study revealed that MTMR6 has an unexpected role in cell line FTE187 cells were obtained from the American preventing cell death (Clague and Lorenzo 2005). Notably, Type Culture Collection (ATCC, Manassas, VA, USA). The MTMR6 was identified as miR-190b-regulated factor that OC cells were cultured in RPMI-1640 medium (Sigma, St. involved in the pathophysiologic mechanism of SIV infection Louis, MO, USA) with 10% fetal bovine serum (FBS, in the intestinal mucosa (Mohan et al. 2014). Sigma). FTE187 cells were kept in ovarian epithelial cell In the present study, the crosstalk between miR-506-3p medium (GIBCO, Carlsbad, CA, USA) with 10% FBS. All and MTMR6 as a cause for OC cancer cells proliferation, cell lines were maintained in a humidified atmosphere con- cell cycle progression and apoptosis, as well as the mecha- taining 5% CO2 at 37°C. nism underline this crosstalk were discovered. Our findings have the potential for broadening our understanding of epi- genetics of caner etiology. 2.3 Cell transfection The miR-506-3p mimics (miR-506-3p) and negative control 2. Materials and methods (miR-NC) were purchased from Shanghai GeneChem Co., Ltd. (Shanghai, China). Two different small interfering 2.1 Clinical tissue samples RNAs for MTMR6 (si-MTMR6-1 and si-MTMR6-2) and si- NC were purchased from RiboBio Co., Ltd (Guangzhou, A total of 20 pairs of tumor tissues and adjacent non-tumor tissues China). The pcDNA3.1-MTMR6 (MTMR6) and pcDNA3.1 were collected from OC patients who underwent surgical resec- empty vector were synthesized by Guangzhou RiboBio Co., tion in the Department of Gynaecology, Yan’an University Ltd. (Guangzhou, China). For cell transfection, OVCAR3 Affiliated Hospital (Shanxi, China) between January 2016 and and SKOV-3 cells were seeded in six-well plates at a density December 2017. Before surgical resection, all patients were of 3 9 105 cells per well and transfected with miR-506-3p, confirmed not to receive chemotherapy or radiotherapy and miR-NC, si-MTMR6 or si-NC. In the rescue experiment, signed the written informed content. The basic clinicopatholog- OVCAR3 cells were co-transfected with miR-506-3p and ical characteristics of all enrolled patients were summarized in MTMR6 plasmids. All cell transfections were performed table 1. The stage for every patient was retrospectively assessed using LipofectamineTM 2000 Reagent (Invitrogen, Carlsbad, based on a modified International Federation of Gynecology and CA, USA) in accordance with the manufacturer’s Obstetrics (FIGO) staging system (Javadi et al. 2016). The col- instructions. lected tissues were immediately snap-frozen and stored in liquid nitrogen. The present study was approved by the Ethics Com- mittee of Yan’an University Affiliated Hospital (Shanxi, China). 2.4 Bioinformatics analysis To predict the potential target genes of miR-506-3p, several 2.2 Cell lines and culture condition software programs, including PicTar 5 (https://pictar.mdc- berlin.de/), TargetScan version 7.1 (http://www.targetscan. Human OC cell lines (ES-2, SKOV-3, HO-8910 and org) and miRBase release 22 (http://www.mirbase.org/) were OVCAR3) and the immortalized fallopian tube epithelial used. MiR-506-3p targets MTMR6 in ovarian cancer Page 3 of 11 126 2.5 Dual luciferase reporter assay Fisher Scientific), called as MTMR6 mutant type (MUT). Then, OVCAR3 and SKOV-3 cells were seeded in 24-well The 30-untranslated regions (30UTRs) of human MTMR6 plates at a density of 2 9 106 cells per well and co-trans- cDNA with the potential target sites for miR-506-3p were fected with 50 pmol of miR-506-3p or miR-NC and 20 ng of amplified and inserted into the psiCHECK2 plasmid (Pro- MTMR6 WT or MTMR6 MUT reporter plasmid using mega Corporation, Madison, WI, USA), named as MTMR6 LipofectamineTM 2000 (Invitrogen, USA). Luciferase wild type (WT). The corresponding site-directed mutagen- activities were quantified 48 h post-transfection using Dual- esis of miR-506-3p in the 30UTR of MTMR6 was performed Luciferase Reporter Assay System (Promega, USA) using Phusion Site-Directed Mutagenesis Kit (Thermo according to the manufacturer’s instructions.
Load more

Recommended publications
  • The Role of PI3P Phosphatases in the Regulation of Autophagy
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 584 (2010) 1313–1318 journal homepage: www.FEBSLetters.org Review The role of PI3P phosphatases in the regulation of autophagy Isabelle Vergne a,*, Vojo Deretic a,b a Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA b Department of Cell Biology and Physiology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA article info abstract Article history: Autophagy initiation is strictly dependent on phosphatidylinositol 3-phosphate (PI3P) synthesis. Received 31 December 2009 PI3P production is under tight control of PI3Kinase, hVps34, in complex with Beclin-1. Mammalian Revised 15 February 2010 cells express several PI3P phosphatases that belong to the myotubularin family. Even though some Accepted 16 February 2010 of them have been linked to serious human diseases, their cellular function is largely unknown. Two Available online 24 February 2010 recent studies indicate that PI3P metabolism involved in autophagy initiation is further regulated by Edited by Noboru Mizushima the PI3P phosphatases Jumpy and MTMR3. Additional pools of PI3P, upstream of mTOR and on the endocytic pathway, may modulate autophagy indirectly, suggesting that other PI3P phosphatases might be involved in this process. This review sums up our knowledge on PI3P phosphatases and Keywords: Autophagy discusses the recent progress on their role in autophagy. Myotubularin Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. PI3P Phosphatase Jumpy MTMR14 1. Introduction PI3P phosphatases were one of the likely candidates as it is known that the phosphoinositide, PI3,4,5P3 and its signaling can be down- PI3P synthesis has long been recognized as one of the key regulated by PI3,4,5P3 phosphatase, PTEN.
    [Show full text]
  • Myotubularin-Related Protein (MTMR) 9 Determines the Enzymatic Activity, Substrate Specificity, and Role in Autophagy of MTMR8
    Myotubularin-related protein (MTMR) 9 determines the enzymatic activity, substrate specificity, and role in autophagy of MTMR8 Jun Zoua,1, Chunfen Zhangb,1,2, Jasna Marjanovicc, Marina V. Kisselevab, Philip W. Majerusb,d,2, and Monita P. Wilsonb,2 aDepartment of Pathology and Immunology, bDivision of Hematology, Department of Internal Medicine, and dDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110; and cDivision of Basic and Pharmaceutical Sciences, St. Louis College of Pharmacy, St. Louis, MO 63110 Contributed by Philip W. Majerus, May 1, 2012 (sent for review February 24, 2012) The myotubularins are a large family of inositol polyphosphate myotubularin proteins (16–21). One mechanism that regulates 3-phosphatases that, despite having common substrates, subsume the myotubularins is the formation of heterodimers between unique functions in cells that are disparate. The myotubularin catalytically active and inactive proteins. The interaction between family consists of 16 different proteins, 9 members of which different myotubularin proteins has a significant effect on en- possess catalytic activity, dephosphorylating phosphatidylinositol zymatic activity. For example, the association of myotubularin 3-phosphate [PtdIns(3)P] and phosphatidylinositol 3,5-bisphos- (MTM1) with MTMR12 results in a threefold increase in the 3- phate [PtdIns(3,5)P2] at the D-3 position. Seven members are in- phosphatase activity of MTM1, alters the subcellular localiza- active because they lack the conserved cysteine residue in the tion of MTM1 from the plasma membrane to the cytosol, and CX5R motif required for activity. We studied a subfamily of homol- attenuates the filopodia formation seen with MTM1 overex- ogous myotubularins, including myotubularin-related protein 6 pression (21, 22).
    [Show full text]
  • Phosphatidylinositol-5-Phosphate Activation and Conserved Substrate Specificity of the Myotubularin Phosphatidylinositol 3-Phosphatases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Current Biology, Vol. 13, 504–509, March 18, 2003, 2003 Elsevier Science Ltd. All rights reserved. DOI 10.1016/S0960-9822(03)00132-5 Phosphatidylinositol-5-Phosphate Activation and Conserved Substrate Specificity of the Myotubularin Phosphatidylinositol 3-Phosphatases 1 2 Julia Schaletzky, Stephen K. Dove, displayed activity toward PtdIns3P and PtdIns(3,5)P2, Benjamin Short,1 Oscar Lorenzo,3 but not the other naturally occurring phosphoinositides 3 1 Michael J. Clague, and Francis A. Barr (Figure 1A). The activity toward PtdIns(3,5)P2 adds a 1Department of Cell Biology novel substrate specificity for MTM1 [6] and is consis- Max-Planck-Institute of Biochemistry tent with reports that MTMR2 and MTMR3 use PtdIns3P Am Klopferspitz 18a and PtdIns(3,5)P2 as substrates [10, 11]. Purified MTMR6 Martinsried, 82152 showed the same substrate specificity as MTM1 (Figure Germany 1C), while the active site mutant protein MTMR6C336S 2 School of Biosciences lacked any detectable activity toward either PtdIns3P University of Birmingham or PtdIns(3,5)P2. To confirm that MTM1 hydrolyses The Medical School PtdIns(3,5)P2, we performed an alternate analysis of activ- Birmingham B15 2TT ity described previously for MTMR3 [10]. This assay is 3 Physiological Laboratory carried out in living yeast cells and is useful for establishing University of Liverpool 3-phosphatase activity against PtdIns(3,5)P2, since it Crown Street allows detection of the reaction product PtdIns5P, which Liverpool L69 3BX is not normally detectable in yeast [10, 12, 13].
    [Show full text]
  • Molecular and Genetic Medicine
    Bertazzi et al., J Mol Genet Med 2015, 8:2 Molecular and Genetic Medicine http://dx.doi.org/10.4172/1747-0862.1000116 Review Article Open Access Myotubularin MTM1 Involved in Centronuclear Myopathy and its Roles in Human and Yeast Cells Dimitri L. Bertazzi#, Johan-Owen De Craene# and Sylvie Friant* Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, France #Authors contributed equally to this work. *Corresponding author: Friant S, Department of Molecular and Cellular Genetics, UMR7156, Université de Strasbourg and CNRS, 67084 Strasbourg, France, E-mail: [email protected] Received date: April 17, 2014; Accepted date: July 21, 2014; Published date: July 28, 2014 Copyright: © 2014 Bertazzi DL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Mutations in the MTM1 gene, encoding the phosphoinositide phosphatase myotubularin, are responsible for the X-linked centronuclear myopathy (XLCNM) or X-linked myotubular myopathy (XLMTM). The MTM1 gene was first identified in 1996 and its function as a PtdIns3P and PtdIns(,5)P2 phosphatase was discovered in 2000. In recent years, very important progress has been made to set up good models to study MTM1 and the XLCNM disease such as knockout or knockin mice, the Labrador Retriever dog, the zebrafish and the yeast Saccharomyces cerevisiae. These helped to better understand the cellular function of MTM1 and of its four conserved domains: PH-GRAM (Pleckstrin Homology-Glucosyltransferase, Rab-like GTPase Activator and Myotubularin), RID (Rac1-Induced recruitment Domain), PTP/DSP (Protein Tyrosine Phosphatase/Dual-Specificity Phosphatase) and SID (SET-protein Interaction Domain).
    [Show full text]
  • Phosphatome Rnai Screen Identifies Eya1 As a Positive Regulator of Hedgehog Signal Transduction
    Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Eisner, Adriana. 2013. Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction. Doctoral dissertation, Harvard University. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11181213 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction A dissertation presented by Adriana Eisner to The Division of Medical Sciences in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Neurobiology Harvard University Cambridge, Massachusetts June 2013 © 2013 Adriana Eisner All rights reserved. Dissertation Advisor: Dr. Rosalind Segal Adriana Eisner Phosphatome RNAi Screen Identifies Eya1 as a Positive Regulator of Hedgehog Signal Transduction Abstract The Hedgehog (Hh) signaling pathway is vital for vertebrate embryogenesis and aberrant activation of the pathway can cause tumorigenesis in humans. In this study, we used a phosphatome RNAi screen for regulators of Hh signaling to identify a member of the Eyes Absent protein family, Eya1, as a positive regulator of Hh signal transduction. Eya1 is both a phosphatase and transcriptional regulator. Eya family members have been implicated in tumor biology, and Eya1 is highly expressed in a particular subtype of medulloblastoma (MB).
    [Show full text]
  • Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1 by Dahlia Doughty Shenton Department of Biochemistry Duke
    Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1 by Dahlia Doughty Shenton Department of Biochemistry Duke University Date: May 1 st 2009 Approved: ___________________________ Dr. Patrick J. Casey, Supervisor ___________________________ Dr. Perry J. Blackshear ___________________________ Dr. Anthony R. Means ___________________________ Dr. Christopher B. Newgard ___________________________ Dr. John D. York Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2009 ABSTRACT Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1 by Dahlia Doughty Shenton Department of Biochemistry Duke University Date: May 1 st 2009 Approved: ___________________________ Dr. Patrick J. Casey, Supervisor ___________________________ Dr. Perry J. Blackshear ___________________________ Dr. Anthony R. Means ___________________________ Dr. Christopher B. Newgard ___________________________ Dr. John D. York An abstract of a dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Biochemistry in the Graduate School of Duke University 2009 Copyright by Dahlia Doughty Shenton 2009 Abstract The dual specificity protein tyrosine phosphatases comprise the largest and most diverse group of protein tyrosine phosphatases and play integral roles in the regulation of cell signaling events. The dual specificity protein tyrosine phosphatases impact multiple
    [Show full text]
  • Expression Profile of Tyrosine Phosphatases in HER2 Breast
    Cellular Oncology 32 (2010) 361–372 361 DOI 10.3233/CLO-2010-0520 IOS Press Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors Maria Antonietta Lucci a, Rosaria Orlandi b, Tiziana Triulzi b, Elda Tagliabue b, Andrea Balsari c and Emma Villa-Moruzzi a,∗ a Department of Experimental Pathology, University of Pisa, Pisa, Italy b Molecular Biology Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy c Department of Human Morphology and Biomedical Sciences, University of Milan, Milan, Italy Abstract. Background: HER2-overexpression promotes malignancy by modulating signalling molecules, which include PTPs/DSPs (protein tyrosine and dual-specificity phosphatases). Our aim was to identify PTPs/DSPs displaying HER2-associated expression alterations. Methods: HER2 activity was modulated in MDA-MB-453 cells and PTPs/DSPs expression was analysed with a DNA oligoar- ray, by RT-PCR and immunoblotting. Two public breast tumor datasets were analysed to identify PTPs/DSPs differentially ex- pressed in HER2-positive tumors. Results: In cells (1) HER2-inhibition up-regulated 4 PTPs (PTPRA, PTPRK, PTPN11, PTPN18) and 11 DSPs (7 MKPs [MAP Kinase Phosphatases], 2 PTP4, 2 MTMRs [Myotubularin related phosphatases]) and down-regulated 7 DSPs (2 MKPs, 2 MTMRs, CDKN3, PTEN, CDC25C); (2) HER2-activation with EGF affected 10 DSPs (5 MKPs, 2 MTMRs, PTP4A1, CDKN3, CDC25B) and PTPN13; 8 DSPs were found in both groups. Furthermore, 7 PTPs/DSPs displayed also altered protein level. Analysis of 2 breast cancer datasets identified 6 differentially expressed DSPs: DUSP6, strongly up-regulated in both datasets; DUSP10 and CDC25B, up-regulated; PTP4A2, CDC14A and MTMR11 down-regulated in one dataset.
    [Show full text]
  • Phosphatases Page 1
    Phosphatases esiRNA ID Gene Name Gene Description Ensembl ID HU-05948-1 ACP1 acid phosphatase 1, soluble ENSG00000143727 HU-01870-1 ACP2 acid phosphatase 2, lysosomal ENSG00000134575 HU-05292-1 ACP5 acid phosphatase 5, tartrate resistant ENSG00000102575 HU-02655-1 ACP6 acid phosphatase 6, lysophosphatidic ENSG00000162836 HU-13465-1 ACPL2 acid phosphatase-like 2 ENSG00000155893 HU-06716-1 ACPP acid phosphatase, prostate ENSG00000014257 HU-15218-1 ACPT acid phosphatase, testicular ENSG00000142513 HU-09496-1 ACYP1 acylphosphatase 1, erythrocyte (common) type ENSG00000119640 HU-04746-1 ALPL alkaline phosphatase, liver ENSG00000162551 HU-14729-1 ALPP alkaline phosphatase, placental ENSG00000163283 HU-14729-1 ALPP alkaline phosphatase, placental ENSG00000163283 HU-14729-1 ALPPL2 alkaline phosphatase, placental-like 2 ENSG00000163286 HU-07767-1 BPGM 2,3-bisphosphoglycerate mutase ENSG00000172331 HU-06476-1 BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 ENSG00000162813 HU-09086-1 CANT1 calcium activated nucleotidase 1 ENSG00000171302 HU-03115-1 CCDC155 coiled-coil domain containing 155 ENSG00000161609 HU-09022-1 CDC14A CDC14 cell division cycle 14 homolog A (S. cerevisiae) ENSG00000079335 HU-11533-1 CDC14B CDC14 cell division cycle 14 homolog B (S. cerevisiae) ENSG00000081377 HU-06323-1 CDC25A cell division cycle 25 homolog A (S. pombe) ENSG00000164045 HU-07288-1 CDC25B cell division cycle 25 homolog B (S. pombe) ENSG00000101224 HU-06033-1 CDKN3 cyclin-dependent kinase inhibitor 3 ENSG00000100526 HU-02274-1 CTDSP1 CTD (carboxy-terminal domain,
    [Show full text]
  • Identification of Myotubularin As the Lipid Phosphatase Catalytic Subunit Associated with the 3-Phosphatase Adapter Protein, 3-PAP
    Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP Harshal H. Nandurkar*†, Meredith Layton‡, Jocelyn Laporte§, Carly Selan*, Lisa Corcoran*¶, Kevin K. Caldwellʈ, Yasuhiro Mochizuki**, Philip W. Majerus**, and Christina A. Mitchell¶ *St. Vincent’s Hospital, 3065 Melbourne, Australia; ‡Ludwig Institute of Medical Research, 3050 Parkville, Australia; §Institute of Genetics and Molecular and Cellular Biology, 67404 Illkirch Cedex, France; ¶Department of Biochemistry and Molecular Biology, Monash University, 3068 Clayton, Australia; ʈDepartment of Neuroscience, University of New Mexico, Albuquerque, NM 87131; and **Department of Haematology, Washington University Medical School, St. Louis, MO 63110 Contributed by Philip W. Majerus, May 21, 2003 Myotubularin is a dual-specific phosphatase that dephosphory- syndrome, a hereditary demyelinating peripheral neuropathy lates phosphatidylinositol 3-phosphate and phosphatidylinositol (17, 18). (3,5)-bisphosphate. Mutations in myotubularin result in the human The catalytically inactive myotubularin family members in- disease X-linked myotubular myopathy, characterized by persis- clude SET-binding factor 1 (MTMR5), LIP-STYX (MTMR9), tence of muscle fibers that retain an immature phenotype. We have MTMR10, the 3-phosphatase adapter protein (3-PAP) previously reported the identification of the 3-phosphatase (MTMR12), and MTMR13 (SET-binding factor 2) (7, 14–16, 19, adapter protein (3-PAP), a catalytically inactive member of the 20). The function of these catalytically inactive phosphatases is myotubularin gene family, which coprecipitates lipid phosphati- unknown. Very recently, mutations in MTMR13 have been dylinositol 3-phosphate-3-phosphatase activity from lysates of described in type 4B2 Charcot Marie Tooth syndrome (19, 20). human platelets. We have now identified myotubularin as the Also, male mice deficient in SET-binding factor 1 are azoosper- catalytically active 3-phosphatase subunit interacting with 3-PAP.
    [Show full text]
  • Protein Tyrosine Phosphatase-PEST (PTP-PEST) Mediates Hypoxia
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.15.152942; this version posted June 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Protein tyrosine phosphatase-PEST (PTP-PEST) mediates hypoxia- 2 induced endothelial autophagy and angiogenesis through AMPK 3 activation. 4 Shivam Chandel1, Amrutha Manikandan1, Nikunj Mehta1, Abel Arul Nathan1, Rakesh 5 Kumar Tiwari1, Samar Bhallabha Mohapatra1, Mahesh Chandran2, Abdul Jaleel2, 6 Narayanan Manoj1 and Madhulika Dixit1. 7 8 1. Department of Biotechnology, 9 Bhupat and Jyoti Mehta School of Biosciences, 10 Indian Institute of Technology Madras (IIT Madras), 11 Chennai, INDIA, 600036 12 2. Rajiv Gandhi Centre for Biotechnology (RGCB), 13 Thyacaud Post, Thiruvananthpuram, 14 Kerala, INDIA, 695014 15 16 Corresponding Author: 17 Madhulika Dixit 18 Department of Biotechnology, 19 Bhupat and Jyoti Mehta School of Biosciences, 20 Indian Institute of Technology Madras 21 Chennai, INDIA, 600036 22 23 Phone: +91-44-22574131 24 E-mail: [email protected] 25 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.15.152942; this version posted June 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 26 Abstract: 27 Global and endothelial loss of PTP-PEST is associated with impaired cardiovascular 28 development and embryonic lethality. Although hypoxia is implicated in vascular 29 morphogenesis and remodelling, its effect on PTP-PEST remains unexplored. Here we 30 report that hypoxia (1% oxygen)increases protein levels and catalytic activity of PTP- 31 PEST in primary endothelial cells.
    [Show full text]
  • Lipid Phosphatases Identified by Screening a Mouse Phosphatase
    Lipid phosphatases identified by screening a mouse PNAS PLUS phosphatase shRNA library regulate T-cell differentiation and Protein kinase B AKT signaling Liying Guoa, Craig Martensb, Daniel Brunob, Stephen F. Porcellab, Hidehiro Yamanea, Stephane M. Caucheteuxa, Jinfang Zhuc, and William E. Paula,1 aCytokine Biology Unit, cMolecular and Cellular Immunoregulation Unit, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and bGenomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840 Contributed by William E. Paul, March 27, 2013 (sent for review December 18, 2012) Screening a complete mouse phosphatase lentiviral shRNA library production (10, 11). Conversely, constitutive expression of active using high-throughput sequencing revealed several phosphatases AKT leads to increased proliferation and enhanced Th1/Th2 cy- that regulate CD4 T-cell differentiation. We concentrated on two lipid tokine production (12). phosphatases, the myotubularin-related protein (MTMR)9 and -7. The amount of PI[3,4,5]P3 and the level of AKT activation are Silencing MTMR9 by shRNA or siRNA resulted in enhanced T-helper tightly controlled by several mechanisms, including breakdown of (Th)1 differentiation and increased Th1 protein kinase B (PKB)/AKT PI[3,4,5]P3, down-regulation of the amount and activity of PI3K, phosphorylation while silencing MTMR7 caused increased Th2 and and the dephosphorylation of AKT (13). PTEN is a major negative Th17 differentiation and increased AKT phosphorylation in these regulator of PI[3,4,5]P3. It removes the 3-phosphate from the cells.
    [Show full text]
  • Lineage-Specific Effector Signatures of Invariant NKT Cells Are Shared Amongst Δγ T, Innate Lymphoid, and Th Cells
    Downloaded from http://www.jimmunol.org/ by guest on October 2, 2021 δγ is online at: average * The Journal of Immunology , 10 of which you can access for free at: 2016; 197:1460-1470; Prepublished online 6 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600643 http://www.jimmunol.org/content/197/4/1460 Lineage-Specific Effector Signatures of Invariant NKT Cells Are Shared amongst T, Innate Lymphoid, and Th Cells You Jeong Lee, Gabriel J. Starrett, Seungeun Thera Lee, Rendong Yang, Christine M. Henzler, Stephen C. Jameson and Kristin A. Hogquist J Immunol cites 41 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2016/07/06/jimmunol.160064 3.DCSupplemental This article http://www.jimmunol.org/content/197/4/1460.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 2, 2021. The Journal of Immunology Lineage-Specific Effector Signatures of Invariant NKT Cells Are Shared amongst gd T, Innate Lymphoid, and Th Cells You Jeong Lee,* Gabriel J.
    [Show full text]